Demographic Characteristics of the Study Cohort (n=115)
| Variable | Number of Patients (%) |
|---|---|
| Age ≤ 40 years | 74 (64.3) |
| Race/ethnicity | |
| Caucasian | 87 (75.7) |
| African American | 17 (14.8) |
| Hispanic/Latino | 2 (1.7) |
| Othera | 9 (7.8) |
| Saw MSM specialist | 36 (31.3) |
| Sexually active | 108 (93.9) |
| Condom use | |
| Consistent | 9 (7.8) |
| Inconsistent | 33 (28.7) |
| Undocumented | 73 (63.5) |
| Prior history of STIs | 20 (17.4) |
| HIV testing | 72 (62.6) |
| STI testing (other than HIV)b | 73 (63.5) |
| Documented PrEP discussion | 34 (29.6) |
| Prescribed PrEP | 20 (17.4) |
↵aAsian, Pacific Islander, other, or declined.
↵bIncluding gonorrhea, chlamydia, syphilis, herpes simplex virus type 1, herpes simplex virus type 2, hepatitis B.
HIV, human immunodeficiency virus; MSM, men who have sex with men; PrEP, pre-exposure prophylaxis (emtricitabine/tenofovir disoproxil fumarate [Truvada]); STI, sexually transmitted infection.